Edward Sturchio
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Edward Sturchio is General Counsel at Immatics NV since 2020.
Formerly, Mr. Sturchio was Secretary, Senior Vice President & General Counsel at Abeona Therapeutics, Inc. from 2019 to 2020, and Secretary & Global General Counsel at Advanced Accelerator Applications SA from 2016 to 2018.
Mr. Sturchio completed undergraduate studies at Villanova University and graduate studies at Seton Hall University School of Law.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMATICS N.V. -.--% | 18.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMATICS N.V. | General Counsel | 01.06.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
| ABEONA THERAPEUTICS INC. | General Counsel | 01.02.2020 |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | General Counsel | 01.08.2018 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Abeona Therapeutics, Inc.
Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advanced Accelerator Applications SA
Advanced Accelerator Applications SA Pharmaceuticals: MajorHealth Technology Develops and produces nuclear medicine and radioligand therapies | Health Technology |
Seton Hall University School of Law
Seton Hall University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immatics NV
Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen